All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Uterine Cervicitis-23203106
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 23203106 A7657C
LCR
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
2 23203106 A7865G
LCR
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
3 23203106 G7622A
LCR
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
4 23203106 G7712C
LCR
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
5 23203106 G7861A
LCR
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
6 23203106 T7624C
LCR
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
7 23203106 T7624G
LCR
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
8 23203106 T7659C
LCR
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
9 23203106 A5571G
L1
L1
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
10 23203106 A5641T
L1
L1
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
11 23203106 A6794G
L1
L1
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
12 23203106 C5640T
L1
L1
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
13 23203106 C6824T
L1
L1
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
14 23203106 C6917A
L1
L1
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
15 23203106 G5642A
L1
L1
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
16 23203106 G6111A
L1
L1
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
17 23203106 G6218A
L1
L1
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
18 23203106 G7802A
L1
L1
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
19 23203106 Q26L
L1
L1
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
20 23203106 T5972C
L1
L1
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
21 23203106 T6701G
L1
L1
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
22 23203106 T6764G
L1
L1
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
23 23203106 A801G
E7
E7
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
24 23203106 C751T
E7
E7
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
25 23203106 A379G
E6
E6
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
26 23203106 G350A
E6
E6
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
27 23203106 K93R
E6
E6
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Uterine Cervicitis
G
R
C
L
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.